- Home
- CNVS vs OBIO Comparison
CNVS vs OBIO Comparison
Compare CNVS & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNVS
- OBIO
- Stock Information
- Founded
- CNVS 2000
- OBIO 2017
- Country
- CNVS United States
- OBIO United States
- Employees
- CNVS 218
- OBIO N/A
- Industry
- CNVS Consumer Electronics/Video Chains
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- CNVS Consumer Discretionary
- OBIO Health Care
- Exchange
- CNVS Nasdaq
- OBIO Nasdaq
- Market Cap
- CNVS 102.4M
- OBIO 118.8M
- IPO Year
- CNVS 2003
- OBIO N/A
- Fundamental
- Price
- CNVS $5.37
- OBIO $2.55
- Analyst Decision
- CNVS Buy
- OBIO Strong Buy
- Analyst Count
- CNVS 1
- OBIO 4
- Target Price
- CNVS $10.00
- OBIO $14.67
- AVG Volume (30 Days)
- CNVS 319.1K
- OBIO 451.7K
- Earning Date
- CNVS 08-14-2025
- OBIO 08-12-2025
- Dividend Yield
- CNVS N/A
- OBIO N/A
- EPS Growth
- CNVS N/A
- OBIO N/A
- EPS
- CNVS 0.13
- OBIO N/A
- Revenue
- CNVS $80,173,000.00
- OBIO $2,944,000.00
- Revenue This Year
- CNVS N/A
- OBIO $19.83
- Revenue Next Year
- CNVS N/A
- OBIO $12.53
- P/E Ratio
- CNVS $40.21
- OBIO N/A
- Revenue Growth
- CNVS 77.07
- OBIO 41.61
- 52 Week Low
- CNVS $0.72
- OBIO $2.37
- 52 Week High
- CNVS $7.39
- OBIO $7.04
- Technical
- Relative Strength Index (RSI)
- CNVS 49.97
- OBIO 42.61
- Support Level
- CNVS $4.62
- OBIO $2.50
- Resistance Level
- CNVS $5.08
- OBIO $2.75
- Average True Range (ATR)
- CNVS 0.45
- OBIO 0.14
- MACD
- CNVS -0.08
- OBIO -0.01
- Stochastic Oscillator
- CNVS 54.64
- OBIO 42.50
About CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.